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Abstract
Background: Cell culture studies show that the antioxidant thiol protein, thioredoxin-1 (Trx1), translocates to cell nuclei
during stress, facilitates DNA binding of transcription factors NF-kB and glucocorticoid receptor (GR) and potentiates
signaling in immune cells. Excessive proinflammatory signaling in vivo contributes to immune hyper-responsiveness and
disease severity, but no studies have addressed whether nuclear Trx1 mediates such responses.
Methodology/Principal Findings: Transgenic mice (Tg) expressing human Trx1 (hTrx1) with added nuclear localization
signal (NLS) showed broad tissue expression and nuclear localization. The role of nuclear Trx1 in inflammatory signaling was
examined in Tg and wild-type (WT) mice following infection with influenza (H1N1) virus. Results showed that Tg mice had
earlier and more extensive NF-kB activation, increased TNF-a and IL-6 expression, greater weight loss, slower recovery and
increased mortality compared to WT. Decreased plasma glutathione (GSH) and oxidized plasma GSH/GSSG redox potential
(EhGSSG) following infection in Tg mice showed that the increased nuclear thiol antioxidant caused a paradoxical
downstream oxidative stress. An independent test of this nuclear reductive stress showed that glucocorticoid-induced
thymocyte apoptosis was increased by NLS-Trx1.
Conclusion/Significance: Increased Trx1 in cell nuclei can increase severity of disease responses by potentiation of redox-
sensitive transcription factor activation.
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Introduction
Thioredoxin-1 (Trx-1) and glutathione (GSH) are central thiol
redox systems in cell nuclei and cytoplasm but are differentially
regulated in these compartments. For instance, during cell stress
induced by nutrient deprivation, proinflammatory signals, oxi-
dants or reactive electrophiles, the nuclear pools are more resistant
to oxidation or depletion [1,2,3]. Although little is known about
the adaptive mechanisms for the nuclear GSH system, the
function of the nuclear Trx1 system is enhanced by translocation
of Trx1 from cytoplasm to nuclei. This translocation is critical to
function of transcription factors that contain a regulatory cysteine
in the DNA binding region, including nuclear factor-kB (NF-kB)
[4,5,6], glucocorticoid receptor (GR) [7,8], activator protein-1
[9,10,11], nuclear factor (erythroid-derived 2)-like 2 (Nrf-2)
[12,13], Hypoxia-inducible factor 1 alpha (HIF-1a) [14] and
p53 [15,16].
Compartmental regulation of NF-kB, AP-1 and Nrf-2 involves
opposing redox-sensitive steps in cytoplasm and nuclei, i.e., 1)
upstream cytoplasmic oxidative activation involving kinase
signaling and 2) downstream Trx1-dependent reduction of the
Cys of the DNA-binding domain [9,17,18,19]. For example,
oxidative signaling in the cytoplasm initiates NF-kB activation via
I-kB kinase, which phosphorylates I-kB causing dissociation and
release of NF-kB for translocation into the nucleus [20]. Excessive
oxidant production oxidizes a critical Cys
62 in the DNA binding
region of NF-kB and inhibits DNA binding [6,18]. Increased
nuclear Trx1 by transient transfection enhances DNA binding and
increases NF-kB reporter activity [5]. Studies with targeted
increases in peroxiredoxin (Prx)-1 further suggest that the nuclear
activation by Trx1 counters an endogenous H2O2-dependent
transcriptional termination mechanism [21].
Modulation of NF-kB signaling by nuclear Trx1 raises the
possibility that excessive nuclear Trx1 could cause hyper-
responsive immune signaling. NF-kB activation is induced by
viruses and viral products, including influenza and HIV, as well
as other stimuli associated with oxidative stress (free radicals, UV
light, gamma-irradiation) [22]. NF-kB modulates the induction of
multiple proinflammatory cytokines, including interleukin (IL)-
1b, IL-6 and tumor necrosis factor (TNF)-a, and is also induced
by these proinflammatory cytokines [22], so that excessive NF-kB
activity due to inadequate nuclear inactivation could contribute
to severity of immune-mediated disease symptoms. Excessive
activation of the immune system has been linked to severity of
infection and death due to H1N1 influenza viral infection
[23,24,25].
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18918Cytoplasmic redox regulation of GR differs from NF-kB, but
increased nuclear Trx1 could similarly contribute to excessive
transcriptional activity. GR is a transcription factor belonging to a
family of nuclear receptors [7,26,27] with different redox-sensitive
steps in the compartments. Unlike the cytoplasmic oxidative
activation described above, GR must be reduced to bind ligand
and be transported into nuclei. During oxidative stress, the Trx1
system in the cytoplasm [7,26,27,28] in combination with the
mitochondrial Trx2 system [29], preserve GR function by
protecting against oxidation. In nuclei, Trx1 directly interacts
with GR through DNA and ligand-binding domains, and
maintains GR in a reduced, active transcriptional state [7,27].
Activation of GR by binding of glucocorticoid hormones (GH)
regulates T-cell survival in positive and negative selection of the
immune system by regulating apoptosis of thymocytes and T
lymphocytes [30,31]. Excessive activation of GR could therefore
contribute to impaired immune functions [32].
Many studies show that oxidative inactivation can disrupt
regulation of transcription and contribute to disease [33,34], but
relatively little information is available concerning the possible
contribution of excessive nuclear reduction. If excessive nuclear
reduction contributed to severity of H1N1 influenza, therapeutic
strategies targeting nuclear Trx1 may prove useful to protect
individuals severely affected because of immune-mediated injury.
To test the possibility that excessive nuclear reduction could
contribute to hyper-responsive immune signaling, we created a
transgenic mouse model (NLS-hTrx1 Tg) in which nuclear Trx1
was increased due to expression of a fusion protein containing
human Trx1 with a nuclear localization signal (NLS). Using this in
vivo model, we show that NF-kB activity is controlled by nuclear
Trx1. Tg mice with H1N1 influenza infection had greater
inflammatory response, including elevated NF-kB activity and
IL-6 and TNF-a induction. This increased response was associated
with impaired body weight recovery and increased mortality due
to the viral infection. In an independent test of the regulatory
function of nuclear Trx1, we observed that increased nuclear Trx1
also potentiated glucocorticoid-stimulated thymocyte death in the
transgenic model. Together, the data show that increased nuclear
Trx1 creates a type of reductive stress in cell nuclei that could
contribute to a hyper-responsive immune activation and represent
a potential target for therapeutic intervention.
Materials and Methods
Ethics Statement
All protocols involving mice were reviewed and approved by the
Institutional Animal Care and Use Committee at Emory
University.
Wild-type and NLS-hTrx1 transgenic mouse
All animal experiments and husbandry for the studies
presented in this manuscript were conducted under the review
and approval of the Emory University Institutional Animal Care
and Use Committee (IACUC, approval ID: DAR-2000040-
062113). Emory IACUC operates under the federal Animal
Welfare Law (administered by the USDA) and regulations of the
Department of Health and Human Services. Mice were
maintained in the Emory University Division of Animal
Resources Facility under a standard 12-h light/dark cycle and
had free access to tap water and standard laboratory diet.
C57BL/6 (WT) mice were purchased from Charles River
Laboratories and used to maintain the transgenic mouse colony,
with WT mice in experiments being littermates of transgenic
mice (Tg) expressing the human Trx1 (hTrx1) gene. The hTrx1
was modified to contain c-Myc epitope tag at the N-terminus
and nuclear localization signal (NLS) at the C-terminus (defined
as NLS-hTrx1 Tg). Preliminary studies using transient transfec-
tion showed that NLS-Trx1 constructs with 1 or 3 copies of the
NLS and a Myc epitope tag were expressed in cells in culture
and showed expected activity in experiments with an NF-kB
reporter assay. NLS-Trx1 constructs were used by the Emory
University Transgenic Mouse Core to create a total of 6
transgenic lines. Briefly, Trx1 cDNA was inserted between the
cytomegalovirus (CMV) promoter and the simian virus (SV-40)
terminator of pCMV-Myc mammalian expression vector pur-
chased from Clontech Laboratories (Mountain View, CA). The
transgenic construct was microinjected into the pronucleus of
fertilized eggs from C57BL/6 mice. The presence of the NLS-
hTrx1 transgene was confirmed by PCR analysis using mouse
genomic DNA prepared from tail biopsy as a template and the
following oligonucleotide primers: forward primer, 59-ATG
GCA TCA ATG CAG AAG CTG ATC T-39; and reverse
primer, 59-GCC GCT GGA TCT TCT ACC TTT CTC T-39
(Integrated DNA technologies, Iowa). Three mouse lines were
created with a single NLS sequence: these showed mRNA
expression for NLS-hTrx1 but no detectable cellular or nuclear
Myc by western blot or fluorescence immunohistochemistry.
Consequently, additional lines were created with 3 tandem
copies of the NLS sequence. These mice appeared phenotypi-
cally normal in terms of weight, activity and appearance, and
one line was selected for study.
Quantification of NLS-hTrx1 and cytokines by real-time
PCR
Total tissue mRNA was isolated using RNeasy Mini kit
purchased from Qiagen (Valencia, CA) following the manufac-
turer’s protocol, and reverse transcription was performed to
generate cDNA (Clontech Laboratories, Mountain View, CA). For
quantitative real-time PCR, amplification was performed on an
iCycler IQ Multicolor Real-Time PCR Detection System (Bio-
Rad Laboratories, Hercules, CA) for 35 cycles as follows: 95uC for
30 seconds, 58uC for 30 seconds, and 72uC for 1 min. Quantifi-
cation and melting curves were analyzed with iCycler software.
Primers for cytokines were designed using a program provided by
Integrated DNA Technologies (Coralville, Iowa). Details of PCR
primer sequences and product sizes for mouse cytokines used in
the analyses of extracted RNA for quantitative real-time PCR are
as follows; IL-1b (180 bp), forward: 59-TGGAGAGTGTG-
GATCCCAAGCAAT-39, reverse: 59-TGTCCTGACCACTGT-
TGTTTCCCA-39; IL-6 (134 bp), forward: 59-ATCCAGTTGC-
CTTCTTGGGACTGA-39, reverse: 59- TAAGCCTCCGACT-
TGTGAAGTGGT-39; IL-10 (147 bp), forward: 59- TGAATT-
CCCTGGGTGAGAAGCTGA-39, reverse: 59- TGGCCTTGT-
AGACACCTTGGTCTT-39; TNFa (140 bp), forward: 59-ACG-
GCATGGATCTCAAAGACAACC-39, reverse: 59- TGAGA-
TAGCAAATCGGCTGACGGT-39; CSF (154 bp), forward: 59-
TGGCTTGGCTTGGGATGATTCTCA-39, reverse: 59- CCC-
ATGGTTTGGTTGCTCTGTTGA-39.
Subcellular fractionation and western blotting
Subcellular fractionation of lung and kidney tissues was
performed using Qproteome kit (Qiagen, Valencia, CA) following
the procedures provided by the manufacturer. These organ
systems were examined because of the expected sensitivity of lung
to influenza virus and because of the abundance of NLS-Trx1 in
the kidney. Twenty mg of kidney and lung from WT and Tg were
processed to isolate cytoplasmic and nuclear fractions. Isolated
fractions were then confirmed by western blotting probed with
Regulation of Transcription Factors by NLS-Trx1
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nuclei, respectively. To examine abundance of other antioxidant
proteins by western blotting, antibodies used were as follows: Myc
(Cell Signaling Technology, Danvers, MA); hTrx1 and mTrx1
(AbFrontier, Seoul, Korea); Trx2 (antisera produced by Covance,
Princeton, NJ); Prx1, Prx2 and Prx3 (Abcam, Cambridge, MA);
Txnip (Invitrogen, Carlsbad, CA); actin (Sigma-Aldrich, St. Louis,
MO); Alexa-Fluor-680-conjugated anti-rabbit or anti-mouse
secondary antibody (Invitrogen). A band corresponding to each
protein was visualized using an Odyssey scanner and Odyssey 2.1
software (Li-Cor, Lincoln, NE).
Nuclear localization by immunohistochemistry and
fluorescence microscopy
Cells isolated from WT and Tg kidneys were plated on glass
cover slips. After 1 d, cells were washed, fixed, stained with anti-
Myc ab followed by Cy3-conjugated goat anti-rabbit ab (Jackson
Immuno Research, West Grove, PA) to visualize nuclear
localization of NLS-hTrx1. Alexa Fluor 488 phalloidin was used
to stain actin. Immunofluorescence was visualized using an
Olympus X-70 fluorescence microscope system.
DNA binding activity measurement by electrophoretic
mobility shift assay (EMSA)
Nuclear extracts prepared from lungs of Tg and WT mice prior
to and 3 d post infection were analyzed using an EMSA
kit (Affymetrics, Clara, CA) by incubating a biotin-labeled or
unlabeled probe containing an NF-kB DNA-binding consensus
sequence (59-AGTTGAGGGGACTTTCCCAGGC-39) with a
Figure 1. mRNA levels of NLS-hTrx1 in different tissues.
Different organs harvested from Tg and littermate WT mice were
analyzed to examine mRNA abundance of nuclear compartment-
targeted hTrx1 and b-actin. Each cDNA converted from purified tissue
RNA (1 mg) by reverse transcription was analyzed by real-time PCR.
Quantified values (picomole) are represented as mean 6 SE for 4 Tg
and 4 WT mice. Symbols are as follows; H, heart; K, kidney; Li, liver; Lu,
lung; SM, skeletal muscle; SI, small intestine; Sp, spleen; Th, thymus.
doi:10.1371/journal.pone.0018918.g001
Figure 2. Nuclear localization of NLS-hTrx1 in Tg mouse. Cells isolated from kidneys of Tg and WT were analyzed to examine localization by
immunofluorescence (A) and western blotting (B). A, Nuclear compartmentalized expression of NLS-hTrx1 was visualized by myc antibody followed
by Cy3 (orange, Tg). As a control, actin distribution in all area of cells was obtained by Alexa Fluor 488 phalloidin, shown for both Tg and WT (green).
Subcellular fractions including cytoplasm and nuclei were obtained from kidney tissues of Tg and WT. Western blotting using each fraction confirmed
nuclear localization of NLS-hTrx1 in Tg. Western blot analysis of lamin and GAPDH were used as markers to verify purity of nuclear and cytoplasmic
fractions, respectively.
doi:10.1371/journal.pone.0018918.g002
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15uC. The samples were analyzed on a 6% nondenaturing PAGE
and electroblotted for 30 min. Signals were detected by
chemiluminescence imaging according to the manufacturer’s
protocol.
Transfection and NF-kB luciferase activity measurement
HeLa cells purchased from ATCC were maintained with 10%
FBS (37uC, 5% CO2) in DMEM. Cells at 80% confluence were
co-transfected with pcDNA3.1, Trx1 WT, or Trx1 C35S [35], and
with pNF-kB Luc (BD science, Franklin Lakes, NJ) plus
pcDNA3.1 containing lacZ gene (Invitrogen) using lipofectamin
(Invitrogen). Two days after transfection, luciferase activity was
measured and normalized for transfection efficiency by b-
galactosidase activity. To initiate luciferase activity, cell lysates
(20 ml) were added to 100 ml to reaction buffer (Promega,
Madison, WI) and luminescence was recorded at 30uC using a
luminometer. b-galactosidase activity was quantified by monitor-
ing cleavage of o-nitrophenyl-b-D-galactopyranoside.
Glutathione (GSH), cysteine (Cys) and related
measurements
Plasma and lung tissue collected from Tg and WT mice 3 d
after infection or with no infection were analyzed for GSH,
glutathione disulfide (GSSG), Cys, and cystine (CySS) by high
performance liquid chromatography (HPLC) with fluorescence
detection [36]. Values were used to calculate the steady-state
redox potential for GSH/GSSG (EhGSSG) and Cys/CySS
(EhCySS) using the measured concentrations, the Nernst equation,
and respective EoGSSG and EoCySS at pH 7.4 for plasma
(2264 mV, 2250 mV) and 7.0 for lung (2240 mV, 2226 mV)
[36,37].
Figure 3. The effect of NLS-hTrx1 on abundance of antioxidant proteins and plasma redox potentials. Protein abundance was
examined by western blot analysis with antibodies specific to Trx1 (NLS-hTrx1 and mTrx1), Prx1, Prx2, Prx3, Txnip, and actin (A). Western blots show
representative data of kidney tissues obtained from 3 Tg mice and littermate WT controls. B, Plasma base line concentrations of cysteine (Cys), cystine
(CySS), glutathione (GSH), and glutathione disulfide (GSSG) in Tg and WT mice were determined by HPLC analyses. Redox potentials of Cys/CySS
(EhCySS) and GSH/GSSG (EhGSSG) were calculated by using the Nernst equation [60].
doi:10.1371/journal.pone.0018918.g003
Figure 4. Effect of influenza virus infection on (A) body weight
and (B) survival in NLS-hTrx1 Tg mice compared to WT
littermates. WT (n=18) and Tg mice (n=17) were infected with
2009 H1N1 influenza A/California/04/2009 virus (16LD50) as described
previously [38]. Body weight and survival rates (WT; 7/18, Tg; 2/17) were
monitored daily and presented as percentages based on day 0.
doi:10.1371/journal.pone.0018918.g004
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H1N1 influenza virus (A/California/04/2009) was kindly
provided by Dr. Richard Webby. The virus was grown in 11-d
old embryonated hen’s eggs for 2 d at 37uC, harvested and stored
at 280uC until use. Mice were infected with serial dilutions of A/
California/04/2009 virus and the 50% lethal dose (LD50) was
determined as described [38].
Wild-type and NLS-hTrx1 transgenic mice (8 to 10 weeks) were
used for infection. Isoflurane-anesthetized mice (18 WT, 17 Tg)
were intranasally infected with 16LD50 of A/California/04/2009
virus (16 the 50% lethal dose, LD50)i n5 0 ml of phosphate-
buffered saline (PBS). Mice were observed daily to monitor
changes in body weight and to record mortality (25% loss in body
weight as the Institutional Animal Care and Use Committee
(IACUC) endpoint for morbidity). For the analysis of lungs at early
time points, additional groups of mice (6 mice for Tg, 5 mice for
WT) were infected and euthanized at 2- or 3-d post infection to
collect lung samples.
Isolation of thymocytes and glucocorticoid-induced cell
death
Thymocytes, from 4 to 6 week-old Tg and WT mice, were
enriched by passage through nylon wool columns. The effects of
glucocorticoid (dexamethasone, Sigma-Aldrich Corp, St. Louis,
MO)-induced apoptosis were evaluated. Cell survival and
death were quantified by measuring absorbance of the dye
product from the nonradioactive quantitative reagent WST-1
(Roche, Basel, Switzerland) and by cell counts using a
hemocytometer.
Statistics
Statistical comparisons of data were carried out using the t-test
of the OriginLab (Data Analysis and Graphing software,
OriginLab Co.). P,0.05 was considered to be significant.
Results
Characteristics of NLS-hTrx1 Tg Mice
To examine tissue distribution of NLS-hTrx1 mRNA, cDNA
converted from total RNA isolated from tissues of littermates with
transgene-positive and -negative genotypes. Results showed
greater abundance of mRNA for NLS-hTrx1 in heart, kidney,
skeletal muscle, and thymus, and lower amounts in liver, lung,
small intestine, and spleen (Fig. 1). Thus, the NLS-Trx1 transgene
is expressed in multiple organ systems as expected based upon the
promoter used.
Characterization of the abundance and localization of the NLS-
hTrx1 transgene product was facilitated by inclusion of the c-Myc
epitope, which allowed discrimination from the endogenous
mouse Trx1. Subcellular localization studies were performed on
kidney because of the relative abundance of the transgenic product
Figure 5. NLS-hTrx1 transgenic mice have increased NF-kB activation and proinflammatory cytokine (TNF-a and IL-6) production
after influenza viral infection. Lung tissues obtained from Tg and WT before (3 mice each for Tg and WT) and 3-d post infection (6 mice for Tg, 5
mice for WT) were examined for mRNA of cytokines (A) and NF-kB activity (B). mRNA levels of TNF-a and IL-6 were analyzed and quantified by real-
time PCR. * p,0.05 for 3-d post infection in Tg compared to 3 d post infection in WT and 0 d in Tg. B, NF-kB activity was examined by EMSA using
same tissues analyzed for cytokines shown in A. Bands indicated as NF-kB bound DNA probe show activity of NF-kB. Densitometry values shown as
fold difference were obtained from measuring relative intensities compared to that in WT before infection (lane 2). [lanes 1–6 are as follows; 1, NF-kB
probe alone; 2, WT before infection; 3, Tg before infection; 4, WT 3 days post infection; 5, Tg 3-d post infection; 6, Tg 3-d post infection (cold NF-kB
probe incubation followed by labeled NF-kB probe incubation)]. C, NF-kB activity (NF-kB Luc) was examined by expression of NLS-hTrx1 WT or
dominant negative mutant of Trx1, NLS-hTrx1 C35S by transient cotransfection with NF-kB luciferase and b-galactosidase. Quantified luciferase
activity as a measure of NF-kB activity was normalized by b-galactosidase [37]. Western blot confirms expression of NLS-hTrx1 WT and NLS-hTrx1
C35S (C, top) and b-actin (C, middle) for equal protein loading in HeLa cells 2 d after transfection. Results of luciferase activity in bar graph are shown
as means 6 SE (n=8, * p,0.05).
doi:10.1371/journal.pone.0018918.g005
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microscopy and the ability to obtain quality nuclear preparations.
Immunofluorescence studies of cells isolated from kidney (Fig. 2A)
using anti-Myc antibody with cy3 (orange), showed NLS-hTrx1
present in cell nuclei of transgenic (Tg) mice (Fig. 2A, top). In
contrast to Tg, WT shows no detection of NLS-hTrx1 in nuclei
while actin was detected in both Tg and WT (Fig. 2A, middle).
Western blot analysis of cytosolic and nuclear fractions of kidney
(Fig. 2B) confirmed these results. Immunoblots of cytoplasmic and
nuclear fractions of kidney tissue obtained from Tg mice shows
nuclear localization of NLS-hTrx1 detected using anti-Myc
antibody (Fig. 2B). Extracts from kidneys of wild-type mice
showed no reactivity. The same blots re-probed with antibodies to
marker proteins, lamin (nuclei) and GAPDH (cytosol), confirmed
the purity of the subcellular fractions. Together, the data show that
the hTrx1 protein is produced and localized to cell nuclei in this
NLS-hTrx1 transgenic mouse model.
We next examined whether expression of NLS-hTrx1 altered
the abundance of other antioxidant proteins including mTrx1,
mitochondrial Trx2, nuclear and cytoplasmic peroxiredoxins
(Prx1, Prx2), mitochondrial Prx3, and thioredoxin-interacting
protein (Txnip). Expression of hTrx1 had no effect on the
abundance of mouse Trx1 but approximately doubled the total
amount of Trx1 (Fig. 3, Top panel). There appeared to be a
slightly higher Prx2 and Txnip in some Tg mice (Fig. 3A) but this
was not significant.
To determine whether increased nuclear Trx1 had a systemic
effect on redox state, we analyzed the redox potentials (Eh)o f
GSH/GSSG and Cys/CySS in plasma. Results show that there
were no significant differences between WT and Tg mice in
concentrations of Cys, CySS, GSH, and GSSG or EhCySS and
EhGSSG (Fig. 3B). Together, the data show that the Tg mice have
increased nuclear Trx1 and that this increase does not have major
effects on other thiol antioxidant components or gross phenotype.
Figure 6. Increased endogenous mouse Trx1 level in nuclei by
infection with influenza H1N1 virus. WT mice infected with
influenza H1N1 virus (A/California/04/2009) at day 3 post infection (day
3) or uninfected WT control mice (day 0) were examined for nuclear
Trx1. Cytoplasm (Cyto) and nuclear (Nuc) fractions of lung tissues (A)
and immune cells isolated from lungs were examined for Trx1 level by
western blot analysis. The same blot was probed with a lamin A/C
antibody as a nuclear protein marker. Results are representatives of 3
analyses.
doi:10.1371/journal.pone.0018918.g006
Figure 7. Changes in GSH/GSSG redox potential (EhGSSG) in Tg and WT following H1N1 influenza virus infection. The same lung
samples described in Fig. 5 were examined for GSH and GSSG concentrations by HPLC, and EhGSSG was calculated using the Nernst equation [60]. No
differences in concentrations or EhGSSG oxidation were observed in lung tissues of Tg or WT following infection, but more oxidation of plasma
EhGSSG was observed in Tg compared to WT. Three mice for each Tg and WT without infection were analyzed as control (0 in A). Plasma GSH, GSSG,
and EhGSSG in Tg and WT before and 3 d post infection are shown in B. * p,0.05.
doi:10.1371/journal.pone.0018918.g007
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infection-induced weight loss and mortality
The 2009 H1N1 influenza virus (A/California/2009) adminis-
tered at the LD50 was pathogenic to both the wild-type and NLS-
hTrx1 transgenic mice as shown by body weight loss (Fig. 4A). The
WT mice showed symptoms of illness, including weight loss,
starting at 4 or 5-d post infection, while the Tg mice showed
weight loss at 3 to 4 d (Fig. 4A). From 6 to 9-d post infection, both
groups of mice suffered severe loss in body weight. The WT mice
had a survival rate of 40% (WT; 7/18 mice, Fig. 4B). The Tg mice
showed only 11.8% survival (Tg; 2/17 mice, Fig. 4B), and
morbidity occurred earlier than in WT. Also, the recovery of Tg
mice from influenza virus infection was delayed compared to WT
mice. These results show that NLS-hTrx1 Tg mice had more
severe disease response to viral infection and did not recover as
well.
NF-kB activation and cytokine expression in Tg mice
infected with influenza
To test whether increased mortality and poor recovery of NLS-
hTrx1 Tg following viral infection was associated with increased
amounts of inflammatory cytokines, we analyzed mRNA levels of
colony stimulating factor (CSF), IL-1b, IL-6, IL-10, and TNFa in
lung tissues of infected mice at 3-d post infection. Both TNFa (Tg,
143.5651.5; WT, 16.067.3, Fig. 5A top) and IL-6 (Tg,
509.36109.2; WT, 79.7621.2, Fig. 5A bottom) were significantly
elevated 3-d after H1N1 infection in WT and Tg mice relative to
untreated controls [TNFa (Tg; 1.0, WT; 1.360.3), IL-6 (Tg; 1.0,
WT; 1.960.2)]. However, the magnitude of the induction for both
(9.0-fold for TNFa and 6.3-fold for IL-6) was much greater in Tg
than WT. There were no significant differences in mRNA levels
for CSF, IL-1b and IL-10 (data not shown).
IL-6 and TNFa are expressed under the control of the
transcription factor NF-kB. To determine if DNA-binding activity
was increased in Tg mice, we analyzed nuclear extracts obtained
from WT and Tg lungs before [lanes 2 (WT) and 3 (Tg) in Fig. 5B]
and 3-d post infection [lanes 4 (WT), 5 (Tg) in Fig. 5B] using an
EMSA without added reductant. The results showed that NF-kB
binding was activated 3-d post infection (Fig. 5B, lane 5: Tg) and
an increased level of activation was present in Tg (lane 5) than WT
(lane 6). The same sample used for lane 5 (Tg, 3-d post infection)
was incubated with unlabeled NF-kB probe before incubation
with labeled NF-kB probe to test specific interaction between NF-
kB and DNA probe (lane 6). The results showed no intensity of
NF-kB-bound labeled probe due to competition between unla-
beled- and labeled NF-kB probes suggesting that NF-kB binding
to the DNA probe is specific. Mean activities of NF-kB (Fig. 5B)
for each lane with respective activity expressed as fold increase
relative to pre-infection WT control (Lane 2) are as follows: 1, 0; 2,
1.0; 3, 1.0; 4, 2.2; 5, 3.7; 6, 1.4.
Since Trx1 regulates NF-kB activation in a redox-dependent
manner, we examined whether increased activation of NF-kBi n
NLS-hTrx1 Tg was regulated by Trx1 through its catalytic redox
activity. To address this question, we used an in vitro, transient
transfection model because a transgenic mouse with a dominant
negative mutant of NLS-hTrx1 is not available. Fig. 5C shows that
NF-kB luciferase activity was elevated by NLS-hTrx1 WT (vector
corresponding to that used to make NLS-hTrx1 Tg mouse) but not
by a dominant negative form, NLS- C35S -hTrx1, supporting
previous data that redox-active Trx1 in cell nuclei controls NF-kB
activation by a redox-dependent mechanism.
Influenza infection is associated with oxidative stress in the
lungs. Since previous findings have shown nuclear translocation of
Trx1 under oxidative stress conditions [39,40], we examined
whether infection with H1N1 influenza virus affected endogenous
levels of Trx1 in lung cell nuclei in WT mice. Results show that
there were small increases in endogenous mouse Trx1 (mTrx1)
levels in nuclei isolated from the lung tissues (Fig. 6A, Day 3) and
immune cells (Fig. 6B, Day 3) of infected mice.
Plasma EhGSSG is oxidized to a greater extent in Tg mice
with viral infection
To determine whether increased nuclear Trx1 protected against
oxidative stress following influenza infection, we measured GSH,
GSSG, Cys and CySS and calculated EhGSSG and EhCySS redox
potentials in lung tissue and plasma before and 3-d post infection
in WT and Tg mice. Lung EhGSSG of both WT and Tg was
significantly oxidized after infection, but there was no statistical
difference between WT and Tg. Lung tissue EhCySS was not
measurable due to low levels of Cys and CySS in tissue. In WT,
viral infection had no significant effect on plasma GSH or plasma
EhGSSG. However, plasma GSH was decreased in Tg after
infection [Fig. 7A bottom: Tg (0 d), 19.261.7 mM; Tg (3 d);
10.961.6 mM] and EhGSSG was more oxidized [Fig. 7A top: Tg
(0 d), 214061.4 mV; Tg (3 d), 2131. 564.8 mV]. EhCySS was
unchanged in Tg and WT at 3-d post infection (data not shown).
Figure 8. Trx1 in nuclei stimulates dexamethasone-induced
death in thymocytes from immature mice. Western blot shows
NLS-hTrx1 expression in thymocytes of Tg mice (A) and in transfected
HeLa cell lysates used as NLS-hTrx1 protein control. Isolated thymocytes
from Tg (6 mice) and WT (6 mice) were incubated with dexamethasone
(Dex, 0, 1, 10 mM) for 4 h. Quantification of surviving cells in each group
was measured 4 h after Dex treatment by WST-1 assay and confirmed
by trypan blue cell counting. (Data are shown as means 6 SE, 3
independent experiments, * p,0.05).
doi:10.1371/journal.pone.0018918.g008
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To determine whether increased nuclear Trx1 could similarly
cause hyper-responsive immune signaling by another transcription
factor with a redox-sensitive Cys in the DNA binding region,
experiments were performed to examine glucocorticoid-stimulated
apoptosis signaling in immature thymocytes. Dexamethasone
(Dex) was used under conditions to cause limited (7%, 4 h) cell
death in WT thymocytes measured by WST-1. Under identical
conditions in Tg thymocytes (Fig. 8A), Dex caused significantly
greater cell death (18%, Fig. 8B). Consequently, the results suggest
that increased nuclear Trx1 could result in excessive signaling by
GH and other transcription factors with redox-sensitive Cys
residues in the DNA-binding regions.
Discussion
Compartmentalized redox regulation is a key component of
redox signaling and regulation of cell functions. Studies by Curran
and coworkers showed that early stress response by AP-1 involved
redox regulation in cell nuclei [9]. DNA binding was inhibited by
oxidation of Fos and Jun, and Trx1 reversed this inhibition in the
presence of NADPH, Trx1 reductase, and a nuclear redox factor
(Ref-1). Ref-1 was found to be an activity of a DNA repair enzyme
apurinic/apyrimidinic endonuclease [41]. Subsequent studies
showed that similar nuclear redox control mechanisms function
for NF-kB, Nrf-2, GR, estrogen receptor, p53 and HIF-1a
[6,8,13,16,17,42]. Importantly, Hirota et al. found that cytoplas-
mic Trx1 suppressed NF-kB activation by UV irradiation, whereas
targeted expression of Trx1 in nuclei enhanced NF-kB activity by
increasing DNA binding [5]. These results clearly discriminated
nuclear and cytoplasmic redox events in transcriptional regulation.
Site-directed mutagenesis suggested that lysine residues near the
C-terminus of Trx1 provide a nuclear targeting sequence [43].
Together, the studies show that in response to oxidative stress,
nuclear Trx1 functions to maintain redox-sensitive transcription
factors in reduced, DNA-binding forms.
Nuclear Trx1 is relatively reduced under non-stressed condi-
tions [44] and highly resistant to oxidation compared to
cytoplasmic Trx1, mitochondrial Trx2 and cellular GSH [3].
Thus, there would not appear to be a need for nuclear
translocation in the absence of oxidative challenge. None-the-less,
Trx1 is found in nuclei of cells at growth boundaries [45]. This
indicates that nuclear translocation of Trx1 occurs in response to
signals other than overt oxidant stress. Nuclear targeting of Prx1, a
Trx1-dependent peroxidase, enhances NF-kB reporter activity
while cytoplasmic targeting of Prx1 blocks this activity [21],
suggesting the existence of a constitutive H2O2-dependent
mechanism to inhibit transcriptional activity. H2O2 production
within nuclei occurs due to oxidative demethylation of histones
[46], and stimulation of oxidant production appears to be a
common event associated with DNA damage and repair [47].
Thus, the pattern of nuclear Trx1 in growth boundaries and the
increase in response to stress may reflect temporal sequences in
which transcriptional activation is followed by a nuclear oxidation
that coordinately decreases activity of redox-sensitive transcription
factors. Together, these observations suggest that nuclear Trx1 has
dual functions in supporting activation of redox-sensitive tran-
scription factors and also in inhibiting inactivation mechanisms
that depend upon endogenous oxidants.
A model incorporating these concepts to account for excessive
immune response due to increased nuclear Trx1 is summarized
Figure 9. A scheme for stimulation of inflammatory response in NLS-hTrx1 Tg by infection. Virus infection and other inflammatory stimuli
affect cytoplasmic redox state, e.g. oxidation of EhGSSG. Cytoplamic oxidation results in phosphorylation and degradation of I-kBa, which then
translocates NF-kB to nucleus. Upon its translocation, p50 subunit (Cys62) reduced by nuclear localized Trx1 together with Ref-1 and Prx stimulates its
DNA binding activity followed by subsequent gene expression, e.g. TNF-a and IL-6. Increased inflammatory cytokines further activate NF-kBa s
feedback stimulation.
doi:10.1371/journal.pone.0018918.g009
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decreased GSH levels by oxidative stress; 2) NF-kBa c t i v a t i o n
and nuclear translocation; 3) elevation of NF-kB activity in
nuclei due to increased abundance of Trx1 (NLS-hTrx1) and
reduction via Ref-1; 4) increased cytokine gene expression by
NF-kB and enhanced immune response; 5) decreased oxidative
inactivation of NF-kB due to enhanced elimination of nuclear
H2O2 by Trx1-dependent Prx-1 and Prx-2; 6) excessive
stimulation of NF-kB activity; and 7) increased morbidity and
mortality from excessive immune response. NF-kB activation is
induced by viruses/viral products as well as other stimuli
associated with oxidative stress (free radicals, UV light, gamma-
irradiation) and could be generally relevant to conditions with
increased signaling by inflammatory cytokines IL-6 [48] and
TNFa [49]. Responses to infection-induced inflammatory stimuli
include feedback stimulation, e.g. NF-kB activation stimulates
inflammatory cytokine up regulations. The response is depen-
dent upon GSH so the redox regulation may be more complex
than implied by this model.
In the absence of viral challenge, the NLS-hTrx1 mice did not
show gross phenotypic differences, e.g., weight, growth, fecundity,
appearance, activity, from WT, and no major effects were
observed in other thiol antioxidant proteins. This suggests that
the present model can be useful to study oxidative processes that
occur in cell nuclei. In this regard, the model adds to the growing
number of mouse models useful to translate compartment-specific
mechanistic information to in vivo function [50,51]. This nuclear
redox model may also be useful in combination with other
compartmental redox models (e.g., Trx2 Tg mouse, [52,53] to
provide tools to help discriminate between toxicological stimuli
targeting nuclear redox functions from those targeting cytoplasmic
and mitochondrial functions. The HeLa cells studies (Fig. 5C),
showed that increased NF-kB luciferase activity due to expression
of NLS-hTrx1 (same vector as used for Tg mouse) was blocked by
the dominant negative NLS-C35S-hTrx1. Consequently, devel-
opment of mouse models with dominant negative Trx1 or an NF-
kB reporter may enhance further understanding of redox control
system in cell nuclei in vivo.
The exacerbation of injury with increased nuclear Trx1 is
distinct from previous Trx1- and Trx2-transgenic mouse studies
that showed protection against injury [39,54,55]. This distinct
characteristic is reflected in the GSH data for lung and plasma
(Fig. 7), which showed that the increased nuclear Trx1 did not
affect cellular GSH or redox potential changes in response to
infection but caused a significant downstream decrease in plasma
GSH and oxidation of plasma EhGSSG. This is consistent with
evidence that reductive stress, as well as oxidative stress, can
contribute to disease mechanisms due to disruption of redox
signaling and control. For instance, recent studies show involve-
ment of reductive stress in cardiomyopathy [56,57]. High levels of
Hsp27 in transgenic mice resulted in cardiac hypertrophy in
association with decreased ROS level, and significant increase in
GSH content and the ratio of GSH/GSSG [57]. A consequence of
reductive stress resulting from Hsp27 over-expression was a
significantly reduced survival rate [57]. Rajasekaran et al. also
demonstrated that cardiomyopathy induced by mutation in
human aB-crystallin was under reductive stress due to elevated
levels of glutathione peroxidase, increased GSH content and the
ratio of GSH/GSSG and c-glutamylcysteine synthetase [56].
Contribution of nuclear Trx1 to hyperactivity of the immune
system could provide the basis for therapeutic development to
inhibit nuclear Trx1 translocation as a means to prevent excessive
activation following influenza infection. With some capacity to
maintain reduction of transcription factors already present in
nuclei, controlling further increase might limit intensity of
activation without blocking necessary activity. Therapeutics
targeting Trx1 translocation may also be useful for adult
respiratory distress and multi-systems organ failure where post-
infection immune responses contribute to tissue injury and death
[58]. This approach could be useful to indirectly control stress-
induced glucocorticoid responses, or in cancer therapeutics,
provide a novel mechanism to control HIF-1a activity [59].
In summary, the present studies with H1N1 influenza viral
infection in NLS-hTrx1 Tg mice show that increased nuclear Trx1
enhances activity of redox-sensitive transcription by NF-kB, causes
exaggerated immune response and contributes to disease severity.
Consistent with this response, redox-sensitive glucocorticoid-
induced cell death was also exacerbated in thymocytes from Tg
compared to WT littermates. Together, the results show that
increased nuclear Trx1 has a critical role in stimulating intensity of
immune responses. This suggests that nuclear translocation of
Trx1 may be a useful therapeutic target to prevent severity of
disease caused by excessive or prolonged activation of redox-
sensitive transcription factors.
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